NewAmsterdam Pharma Co NV (NAMS)
25.71
+0.11
(+0.43%)
USD |
NASDAQ |
Dec 31, 16:00
25.71
0.00 (0.00%)
After-Hours: 20:00
NewAmsterdam Pharma Shareholders Equity (Quarterly): 378.86M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| argenx SE | -- |
| uniQure NV | 55.82M |
| ProQR Therapeutics NV | 27.90M |
| Merus NV | 703.26M |
| Pharming Group | 225.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 439.19M |
| Total Liabilities (Quarterly) | 60.33M |
| Current Ratio | 10.61 |